everolimus
Not Tagged
['everest', 'rcc,(-irccs),(-srcc),(-urcc)']
everest: adjuvant everolimus in rcc. another trial that falls short in this setting. low risk (pt1-2) patients included, poor safety profile, lower than expected event rate we need to do better than this. #asco22 
Medical Oncologist - Urologic Oncology. Hospital Universitario La Paz - IdiPAZ, Madrid